Unplanned Hospital Visits in the First 30 Days After Urethral Sling Procedures.

[1]  A. Cohen,et al.  30-Day Morbidity and Reoperation Following Midurethral Sling: Analysis of 8772 Cases Using a National Prospective Database. , 2016, Urology.

[2]  J. Winick-Ng,et al.  Removal or Revision of Vaginal Mesh Used for the Treatment of Stress Urinary Incontinence. , 2015, JAMA surgery.

[3]  C. Elliott,et al.  Might Pelvic Surgeons Be Unaware of Their Surgical Failures? Patient Reporting and Perceptions After Failed Incontinence or Pelvic Organ Prolapse Surgery , 2015, Female pelvic medicine & reconstructive surgery.

[4]  J. Jelovsek,et al.  Assessment of voiding after sling: a randomized trial of 2 methods of postoperative catheter management after midurethral sling surgery for stress urinary incontinence in women. , 2015, American journal of obstetrics and gynecology.

[5]  Jennifer M Wu,et al.  Lifetime Risk of Stress Urinary Incontinence or Pelvic Organ Prolapse Surgery , 2014, Obstetrics and gynecology.

[6]  L. Kao,et al.  Reliability of risk-adjusted outcomes for profiling hospital surgical quality. , 2014, JAMA Surgery.

[7]  J. Eastham,et al.  Midurethral sling is the dominant procedure for female stress urinary incontinence: analysis of case logs from certifying American Urologists. , 2013, Urology.

[8]  Jennifer M Wu,et al.  Sling revision/removal for mesh erosion and urinary retention: long-term risk and predictors. , 2012, American journal of obstetrics and gynecology.

[9]  J. Kusek,et al.  Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. , 2011, American journal of obstetrics and gynecology.

[10]  C. Ko,et al.  Reliability Of Superficial Surgical Site Infections As A Hospital Quality Measure , 2011 .